Chief Operating Officer · STANDARD BIOTOOLS INC. (LAB)

Hanjoon Kim

A named executive officer of STANDARD BIOTOOLS in every fiscal year CompBrief holds from FY2022 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$909,788

Salary $430,000Stock awards $186,788

FY2022: $5,856,938

4th of 4 named executive officers at Standard Biotools by FY2023 total.

4 named officers on file for STANDARD BIOTOOLS, FY2023

Hanjoon Kim’s pay file — $29

  • 2 fiscal years of pay, line by line
  • LAB’s disclosed peer group of 22 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how STANDARD BIOTOOLS’s whole pay program stands against its peers

  • STANDARD BIOTOOLS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on LAB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 21, 2024 (DEF 14A).

Free

Get Hanjoon Kim’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Hanjoon Kim compensation by year

STANDARD BIOTOOLS Summary Compensation Table · all 2 fiscal years held
In US dollars, as STANDARD BIOTOOLS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023
Salary$298,485$430,000
Bonus$0$0
Stock awards$1,120,121$186,788
Option awards$4,372,645$0
Non-equity incentive$62,687$290,000
Pension and deferred compensation$0$0
All other$3,000$3,000
Total$5,856,938$909,788

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: STANDARD BIOTOOLS INC. DEF 14A filed May 21, 2024, accession 0001140361-24-027068, and prior-year filings. Open the filing on EDGAR.

How this page was built: the STANDARD BIOTOOLS INC. filed document, accession 0001140361-24-027068. Every figure is read from that document and cited to the page and table it appears in. Filed May 21, 2024.

$5.9M
$910K
FY22
FY23
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU210,549$465,313—
RSU77,185$170,579—
Option943,699—$3.99

Per the Outstanding Equity Awards at Fiscal Year-End table in STANDARD BIOTOOLS INC.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

STANDARD BIOTOOLS’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Michael EgholmPresident, Chief Executive Officer and Director$1,931,088
Jeffrey BlackChief Financial Officer$1,492,297
Jeremy DavisChief Commercial Officer$1,277,557
Hanjoon Kim · this pageChief Operating Officer$909,788

The full STANDARD BIOTOOLS compensation record

free company brief

This page is one person within STANDARD BIOTOOLS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are STANDARD BIOTOOLS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Hanjoon Kim's compensation dossier · One-time report. No refunds.